Over the past decade, pharmaceutical and life sciences companies have entered a difficult period where shareholders, the market and regulators have all created significant pressures for change within the industry. From thinning pipelines and skyrocketing operating costs to calls for lower prices and a greater regulatory burden, the industry is confronting unprecedented challenges that are expected to radically transform the business.
Nexus holds the view that despite tremendous demand for its products, the industry's current business model is both economically unsustainable and operationally unsuited to act quickly enough to produce the types of innovative treatments that will be demanded by global markets. In our report, we state that, to flourish, companies will need to invest more in research, understand and demonstrate the value of their products, lower the cost of distribution, collaborate with partners at home and abroad, and provide value-added services to their customers. Though these and other changes that lie ahead are daunting, we believe that the rewards both in terms of human health and business success are enormous.
Pharmaceuticals industry challenges
- Attracting and retaining a skilled workforce
- Controlling operating costs
- Generic competition
- Intellectual property protection
- Managing regulatory compliance
- Pricing pressures and shrinking margins
- Realizing tangible value from strategic alliances, joint ventures (JVs) and partnering arrangements
- Reputation management
- Successfully developing innovative drugs and enhancing research & development productivity
- Sustaining growth in global markets
How Nexus can help you
Our firm has extensive experience working with organizations across the industry, including: proprietary and generic drug manufacturers, specialty drug makers, medical device and diagnostics suppliers, biotechnology companies, wholesalers, pharmacy benefit managers, contract research organizations, and industry associations. We have made a deep commitment to understanding the forces affecting our clients' operations and have aligned our practice with the market to ensure that our people are deeply knowledgeable about the relationships that suppliers have with providers, payers, regulators and patients.
Whether you are an emerging company seeking venture capital to fund research or advice on a collaboration to commercialize a product, or an established company looking to improve or expand operations, you can count on our insight and experience to find the best approaches to achieve your financial, operational and strategic objectives. |
